Health Canada has approved the first drug designed to treat postpartum depression. The regulator says zuranolone, a pill sold ...

A much-awaited treatment for postpartum depression, zuranolone, hit the market in December, promising an accessible and fast-acting medication for a debilitating illness. But most private health ...

Two years after the FDA approved a unique pill designed to treat postpartum depression, an analysis at Scientific American ...

The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression - making it the first FDA-approved oral pill in the United States specifically for ...

NEW YORK (WABC) -- The Food and Drug Administration is reviewing the application for a new medication, which, if approved, would become the first drug specifically indicated for postpartum depression.

Zuranolone is a pill taken once a day for 14 days and can start relieving depressive symptoms in as few as three days ...